Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,507 INR | -0.89% | -1.07% | +19.62% |
Sales 2024 * | 485B 5.82B | Sales 2025 * | 538B 6.46B | Capitalization | 3,615B 43.35B |
---|---|---|---|---|---|
Net income 2024 * | 93.04B 1.12B | Net income 2025 * | 113B 1.35B | EV / Sales 2024 * | 7.25 x |
Net cash position 2024 * | 97.98B 1.18B | Net cash position 2025 * | 161B 1.93B | EV / Sales 2025 * | 6.41 x |
P/E ratio 2024 * |
38.5
x | P/E ratio 2025 * |
32
x | Employees | 41,000 |
Yield 2024 * |
0.82% | Yield 2025 * |
0.95% | Free-Float | 45.31% |
Latest transcript on Sun Pharmaceutical Industries Ltd.
1 day | -0.89% | ||
1 week | -1.07% | ||
Current month | -7.03% | ||
1 month | -5.73% | ||
3 months | +10.10% | ||
6 months | +36.50% | ||
Current year | +19.62% |
Managers | Title | Age | Since |
---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
Founder | 68 | 01/82/01 | |
Director of Finance/CFO | - | 19/17/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 68 | 01/82/01 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/21/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 63 | 15/23/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.72% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1,507 | -0.89% | 1,794,350 |
25/24/25 | 1,520 | +2.32% | 3,846,327 |
24/24/24 | 1,486 | +0.07% | 4,652,803 |
23/24/23 | 1,485 | -3.60% | 9,160,422 |
22/24/22 | 1,540 | +1.14% | 1,680,307 |
Delayed Quote NSE India S.E., April 26, 2024 at 05:13 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B | |
-4.29% | 4.71B |
- Stock Market
- Equities
- SUNPHARMA Stock